Summary | Advisers are steering some of their well-heeled,
yield-hungry clients toward health-health-care royalty funds,
which tap into the revenue streams of medical patent holders.
Funds typically invest in a basket of different royalties, and
can focus on different stages, such as drugs or medical devices
already on the market or those in earlier stages of development ...
yield-hungry clients toward health-health-care royalty funds,
which tap into the revenue streams of medical patent holders.
Funds typically invest in a basket of different royalties, and
can focus on different stages, such as drugs or medical devices
already on the market or those in earlier stages of development ...
blogs.wsj.com | 26 May 2015